Gene · 7486
Papers3,630
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,630
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Structural insights into WRN helicase reveal conformational states and opportunities for MSI-H cancer drug discovery. | Commun Biol | 2026 | 41606312 | PubTator, text mining | PubMed |
| Novel Homozygous Variants in CIDEC and WRN in a Young Female with Lipodystrophy and Thyroid Cancer. | Int J Mol Sci | 2026 | 41596298 | PubTator, text mining | PubMed |
| BMI1 represses G-quadruplex DNA formation to maintain genomic stability during replication. | J Biol Chem | 2026 | 41570993 | PubTator, text mining | PubMed |
| Photoclick chemistry led to the identification of HELLS as a helicase for DNA G-quadruplexes. | Nucleic Acids Res | 2026 | 41569154 | PubTator, text mining | PubMed |
| SNORA49 negatively regulates self-renewal of liver cancer stem cells and hepatocarcinogenesis via suppressing SOX9 transcription. | Nat Commun | 2026 | 41565615 | PubTator, text mining | PubMed |
| The Werner syndrome RECQ helicase as a therapeutic target: new insights. | Expert Opin Ther Targets | 2026 | 41557499 | PubTator, text mining | PubMed |
| Stability of non-canonical nucleic acid structure as a potential modulator of cell fate. | Nucleic Acids Res | 2026 | 41533566 | PubTator, text mining | PubMed |
| WRN structural flexibility showcased through fragment-based lead discovery of inhibitors. | Nat Commun | 2026 | 41484101 | PubTator, text mining | PubMed |
| Efficacy and safety of SGLT2 inhibitor on insulin resistance and hyperglycemia in Werner syndrome-A case report. | J Diabetes Investig | 2026 | 41316811 | PubTator, text mining | PubMed |
| The bacterial MRE11-RAD50 and DNA2-WRN homologs process replication forks at distinct and separate loci on the chromosome. | FEBS Lett | 2026 | 41168947 | PubTator, text mining | PubMed |
| Drugging the DNA damage response in the clinic: going beyond PARP. | Expert Rev Anticancer Ther | 2026 | 41086259 | PubTator, text mining | PubMed |
| AI-assisted delivery of novel covalent WRN inhibitors from a non-covalent fragment screen. | Bioorg Med Chem Lett | 2026 | 41038585 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Proliferative Senescence and Genomic Instability in Werner Syndrome and the WRN Gene Network. | Cytogenet Genome Res | 2026 | 40971347 | PubTator, text mining | PubMed |
| Post-Translational Modifications of the Werner Syndrome Protein WRN. | Cytogenet Genome Res | 2026 | 40602371 | PubTator, text mining | PubMed |
| Design and synthesis of 2-amino-4-(trifluoromethyl)pyrimidine derivatives as potential Werner-dependent antiproliferative agents. | Mol Divers | 2026 | 40517347 | PubTator, text mining | PubMed |
| Discovery of novel quinazoline derivatives containing trifluoromethyl against cell proliferation by targeting werner helicase. | Mol Divers | 2026 | 40148606 | PubTator, text mining | PubMed |
| Genetic and Epigenetic Insights into Werner Syndrome. | Cytogenet Genome Res | 2026 | 39956107 | PubTator, text mining | PubMed |
| Application and Prospects of Large Language Models in Small-Molecule Drug Discovery. | Anal Chem | 2025 | 41366732 | PubTator, text mining | PubMed |
| Context-aware gene dependency modeling via graph attention networks for precision oncology. | J Transl Med | 2025 | 41291726 | PubTator, text mining | PubMed |
| Targeting DNA Damage Repair Pathways Beyond PARP Inhibition. | Target Oncol | 2025 | 41240294 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7486/papers?page=4